| - GRCh37:
- Chr6:32007182
- GRCh38:
- Chr6:32039405
| CYP21A2, LOC106780800 | S136C, S166C, S31C | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Apr 17, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006290
- GRCh38:
- Chr6:32038513
| CYP21A2, LOC106780800 | P31S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Apr 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006236
- GRCh38:
- Chr6:32038459
| CYP21A2, LOC106780800 | L13M | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Jan 20, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006303
- GRCh38:
- Chr6:32038526
| CYP21A2, LOC106780800 | P35L | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Jan 20, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007587
- Chr6:32007584
- GRCh38:
- Chr6:32039810
- Chr6:32039807
| CYP21A2, LOC106780800, LOC106780800, CYP21A2 | V238E, V103E, V208E, I237N, I207N, I102N | Congenital adrenal hyperplasia | Pathogenic (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007587
- Chr6:32007593
- GRCh38:
- Chr6:32039810
- Chr6:32039816
| CYP21A2, LOC106780800, LOC106780800, CYP21A2 | V238E, V103E, V208E, M240K, M105K, M210K | not specified | Uncertain significance (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007593
- Chr6:32007584
- GRCh38:
- Chr6:32039816
- Chr6:32039807
| LOC106780800, CYP21A2, LOC106780800, CYP21A2 | M240K, M105K, M210K, I237N, I207N, I102N | not specified | Uncertain significance (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007188
- GRCh38:
- Chr6:32039411
| CYP21A2, LOC106780800 | L138P, L168P, L33P | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007387
- GRCh38:
- Chr6:32039610
| CYP21A2, LOC106780800 | W175*, W205*, W70* | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006919
- GRCh38:
- Chr6:32039142
| CYP21A2, LOC106780800 | S114F, S84F | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007009
- GRCh38:
- Chr6:32039232
| CYP21A2, LOC106780800 | Q10fs, Q115fs, Q145fs | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006589
- GRCh38:
- Chr6:32038812
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007960
- GRCh38:
- Chr6:32040183
| CYP21A2, LOC106780800 | L173fs, L278fs, L308fs | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008342
- GRCh38:
- Chr6:32040565
| CYP21A2, LOC106780800 | R232C, R337C, R367C | Congenital adrenal hyperplasia, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Conflicting interpretations of pathogenicity (Mar 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32008540
- GRCh38:
- Chr6:32040763
| CYP21A2, LOC106780800 | F270S, F375S, F405S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007962
- GRCh38:
- Chr6:32040185
| CYP21A2, LOC106780800 | F172V, F277V, F307V | not provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Conflicting interpretations of pathogenicity (Feb 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32007956
- GRCh38:
- Chr6:32040179
| CYP21A2, LOC106780800 | V170M, V275M, V305M | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006951
- GRCh38:
- Chr6:32039174
| CYP21A2, LOC106780800 | R125C, R95C | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008313
- GRCh38:
- Chr6:32040536
| CYP21A2, LOC106780800 | R222Q, R327Q, R357Q | not provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Conflicting interpretations of pathogenicity (Jun 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32008330
- GRCh38:
- Chr6:32040553
| CYP21A2, LOC106780800 | A228P, A333P, A363P | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008306
- GRCh38:
- Chr6:32040529
| CYP21A2, LOC106780800 | R220C, R325C, R355C | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007612
- GRCh38:
- Chr6:32039835
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008307
- GRCh38:
- Chr6:32040530
| CYP21A2, LOC106780800 | R325P, R355P, R220P | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007878
- GRCh38:
- Chr6:32040101
| CYP21A2, LOC106780800 | E249K, E279K, E144K | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008362
- GRCh38:
- Chr6:32040585
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007987
- GRCh38:
- Chr6:32040210
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006982
- GRCh38:
- Chr6:32039205
| CYP21A2, LOC106780800 | M136fs, M106fs | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007525
- GRCh38:
- Chr6:32039748
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008262
- GRCh38:
- Chr6:32040485
| CYP21A2, LOC106780800 | R205H, R310H, R340H | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (Jul 26, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008318
- GRCh38:
- Chr6:32040541
| CYP21A2, LOC106780800 | V224I, V329I, V359I | not provided | Uncertain significance (Jul 29, 2021) | criteria provided, single submitter |
| | CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Jul 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:51504638
- GRCh38:
- Chr15:51212441
| CYP19A1, MIR4713HG, PIRC66 | D381V | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008285
- GRCh38:
- Chr6:32040508
| CYP21A2, LOC106780800 | A213T, A318T, A348T | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:32006342
- GRCh38:
- Chr6:32038565
| CYP21A2, LOC106780800 | Y48C | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32008874
- GRCh38:
- Chr6:32041097
| CYP21A2, LOC106780800 | R349P, R454P, R484P | not provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Conflicting interpretations of pathogenicity (May 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32008697
- GRCh38:
- Chr6:32040920
| CYP21A2, LOC106780800 | G290V, G395V, G425V | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:32007875-32007876
- GRCh38:
- Chr6:32040098-32040099
| CYP21A2, LOC106780800 | E144fs, E249fs, E279fs | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 18, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007426
- GRCh38:
- Chr6:32039649
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 18, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006239
- GRCh38:
- Chr6:32038462
| CYP21A2, LOC106780800 | A14S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008363
- GRCh38:
- Chr6:32040586
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (Apr 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008313
- GRCh38:
- Chr6:32040536
| CYP21A2, LOC106780800 | R222P, R327P, R357P | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not provided | Conflicting interpretations of pathogenicity (Mar 10, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32006087
- GRCh38:
- Chr6:32038310
| LOC106780800, LOC110631417, CYP21A2 | | Congenital adrenal hyperplasia | Likely pathogenic (Mar 16, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr7:75612803
- GRCh38:
- Chr7:75983485
| LOC126860075, POR | | not provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign/Likely benign (Mar 3, 2015) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32007846
- GRCh38:
- Chr6:32040069
| CYP21A2, LOC106780800 | P133L, P238L, P268L | not provided, not specified, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
| Benign/Likely benign (Dec 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32008696
- GRCh38:
- Chr6:32040919
| CYP21A2, LOC106780800 | G290S, G425S, G395S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not provided | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32007840
- GRCh38:
- Chr6:32040063
| CYP21A2, LOC106780800 | A236V, A266V, A131V | not specified, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Conflicting interpretations of pathogenicity (Feb 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32007370
- GRCh38:
- Chr6:32039593
| CYP21A2, LOC106780800 | L64F, L199F, L169F | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not provided | Conflicting interpretations of pathogenicity (May 28, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32007893
- GRCh38:
- Chr6:32040116
| CYP21A2, LOC106780800 | M254V, M284V, M149V | not provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32007825
- GRCh38:
- Chr6:32040048
| LOC106780800, CYP21A2 | M126T, M231T, M261T | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007825
- GRCh38:
- Chr6:32040048
| LOC106780800, CYP21A2 | M126R, M231R, M261R | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007797
- GRCh38:
- Chr6:32040020
| CYP21A2, LOC106780800 | G117S, G222S, G252S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007708
- GRCh38:
- Chr6:32039931
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007687
- GRCh38:
- Chr6:32039910
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32007598
- GRCh38:
- Chr6:32039821
| CYP21A2, LOC106780800 | L107V, L212V, L242V | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007521
- GRCh38:
- Chr6:32039744
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007459
- GRCh38:
- Chr6:32039682
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007454
- GRCh38:
- Chr6:32039677
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007332
- GRCh38:
- Chr6:32039555
| LOC106780800, CYP21A2 | L157V, L187V, L52V | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Likely pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007304
- GRCh38:
- Chr6:32039527
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007225
- GRCh38:
- Chr6:32039448
| LOC106780800, CYP21A2 | D150E, D180E, D45E | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007210
- GRCh38:
- Chr6:32039433
| LOC106780800, CYP21A2 | Y145*, Y175*, Y40* | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007194
- GRCh38:
- Chr6:32039417
| CYP21A2, LOC106780800 | C140Y, C170Y, C35Y | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007185
- GRCh38:
- Chr6:32039408
| LOC106780800, CYP21A2 | L137R, L167R, L32R | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007184
- GRCh38:
- Chr6:32039407
| LOC106780800, CYP21A2 | L137V, L167V, L32V | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007170
- GRCh38:
- Chr6:32039393
| LOC106780800, CYP21A2 | E132G, E162G, E27G | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007130
- GRCh38:
- Chr6:32039353
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007083
- GRCh38:
- Chr6:32039306
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007064
- GRCh38:
- Chr6:32039287
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007063
- GRCh38:
- Chr6:32039286
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006983
- GRCh38:
- Chr6:32039206
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006960
- GRCh38:
- Chr6:32039183
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006900
- GRCh38:
- Chr6:32039123
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008929
- GRCh38:
- Chr6:32041152
| CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008913
- GRCh38:
- Chr6:32041136
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008869-32008870
- GRCh38:
- Chr6:32041092-32041093
| CYP21A2, LOC106780800 | R349fs, R484fs, R454fs | not provided | Likely pathogenic (Apr 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008870
- GRCh38:
- Chr6:32041093
| LOC106780800, CYP21A2 | P348T, P453T, P483T | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008828
- GRCh38:
- Chr6:32041051
| CYP21A2, LOC106780800 | S334G, S439G, S469G | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008794
- GRCh38:
- Chr6:32041017
| LOC106780800, CYP21A2 | D322E, D427E, D457E | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008743
- GRCh38:
- Chr6:32040966
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008721
- GRCh38:
- Chr6:32040944
| CYP21A2, LOC106780800 | P298R, P403R, P433R | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008714
- GRCh38:
- Chr6:32040937
| LOC106780800, CYP21A2 | G296S, G401S, G431S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008695
- GRCh38:
- Chr6:32040918
| CYP21A2, LOC106780800 | C289*, C394*, C424* | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Pathogenic (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008643
- GRCh38:
- Chr6:32040866
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008625
- GRCh38:
- Chr6:32040848
| LOC106780800, TNXB, CYP21A2 | | not provided | Likely benign (May 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008527
- GRCh38:
- Chr6:32040750
| LOC106780800, CYP21A2 | R266G, R371G, R401G | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008496
- GRCh38:
- Chr6:32040719
| LOC106780800, CYP21A2 | Q255H, Q360H, Q390H | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32008458
- GRCh38:
- Chr6:32040681
| CYP21A2, LOC106780800 | D243Y, D348Y, D378Y | not specified | Uncertain significance (Apr 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32008352
- GRCh38:
- Chr6:32040575
| LOC106780800, CYP21A2 | R235P, R340P, R370P | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32007899
- GRCh38:
- Chr6:32040122
| CYP21A2, LOC106780800 | A151S, A256S, A286S | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006791
- GRCh38:
- Chr6:32039014
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006783
- GRCh38:
- Chr6:32039006
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006782
- GRCh38:
- Chr6:32039005
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006780
- GRCh38:
- Chr6:32039003
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006777
- GRCh38:
- Chr6:32039000
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006776
- GRCh38:
- Chr6:32038999
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006775
- GRCh38:
- Chr6:32038998
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006756
- GRCh38:
- Chr6:32038979
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006741
- GRCh38:
- Chr6:32038964
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Benign (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006771-32006772
- GRCh38:
- Chr6:32038994-32038995
| LOC106780800, CYP21A2 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:32006739-32006740
- GRCh38:
- Chr6:32038962-32038963
| CYP21A2, LOC106780800 | | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Uncertain significance (May 24, 2019) | no assertion criteria provided |